Insulin affordability is an ongoing discussion topic for patients with diabetes and their care providers. The already difficult issue has been further compounded by the ongoing COVID-19 pandemic.
Three patients with type 2 diabetes in different stages of life and disease all require insulin management for A1c control.
Insulin degludec vs glargine--which costs less per anum and why? We summarize this study and 2 other direct insulin comparisons reported at ADA 2017.
Stringent control was supported even in patients at high risk for related harm. Reasons found for concern over Rx "deintensification" may surprise you.
Here’s a look at what’s new and interesting on the Web for health care professionals.
Maintaining tight glycemic control in older diabetic adults who are in poor health can do far more harm than good, according to results of a new study.
Activation of opioid receptors with novel approaches may prevent hypoglycemia and lead to safer intensive glycemic control, according to a study reported at the American Diabetes Association 74th Scientific Sessions.
The fact that a "Diabetes Is Primary" session is held in parallel to the ADA scientific sessions is a significant recognition by the American Diabetes Association that primary care providers are the foundation of diabetes care in the United States. Highlights here.
The use of insulin has grown in recent years largely because of the widespread adoption of analogs. Out-of-pocket expenditures per prescription also increased.
Remembering the role the patient can play in preventing medication errors is important. Here I focus on potential errors resulting from nonadherence with insulin.